Corporate Finance/M&A

Increased activity in mergers and acquisitions and renewed capital markets appetite for certain initial public offerings (IPOs) provide companies with an opportunity to revisit their business portfolios and look for ways to increase the value of their businesses.

Mergers and acquisitions are important strategic tools. It is true that more than half of all corporate transactions have destroyed value. However, an interesting acquisition opportunity may allow a company to, in the short-term, engage in a new business or area of interest, reach critical mass, build a presence in a new geographical market, acquire new capabilities, exploit economies of scale and synergies or diversify its business or product portfolio.

We work with Clients in assessing the strategic fit of acquisition opportunities, conduct due diligence on the target, assess the true value of potential L&A (projects, products) and M&A (target companies) opportunities, and support the post-M&A processes. We are unique in bridging the gap between strategy consultants and transaction advisors, working with Clients through the deal process, negotiation tactics and pricing. Due to our global network in the healthcare industry and existing relationships with investment banks, we are aware of a range of licensing and M&A opportunities.